SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-005062
Filing Date
2020-01-27
Accepted
2020-01-27 19:53:31
Documents
1
Period of Report
2019-08-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3514
  Complete submission text file 0001209191-20-005062.txt   4981
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address
Cai Veronica (Reporting) CIK: 0001801322 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 20551078